Profiel
Mark J.
Murray was the founder of Protiva Biotherapeutics, Inc., founded in 2000, where the title held was President & Chief Executive Officer from 2000 to 2008.
The current job is Director at Genevant Sciences Corp.
Former job includes President, Chief Executive Officer & Director at Arbutus Biopharma Corp.
from 2011 to 2019.
Education includes a doctorate from Oregon Health & Science University.
Actieve functies van Mark Murray
| Bedrijven | Functie | Begin |
|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Algemeen Directeur | 24-06-2019 |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Algemeen Directeur | 02-12-2008 |
Opleiding van Mark Murray
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Oregon Health & Science University
Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















